首页|期刊导航|中国中医骨伤科杂志|中西医结合方案(接骨续损汤联合督灸)对老年股骨骨折延迟愈合患者的干预效果及机制研究

中西医结合方案(接骨续损汤联合督灸)对老年股骨骨折延迟愈合患者的干预效果及机制研究OA

Study on the Intervention Effect and Mechanism of the Integrated Traditional Chinese and Western Medicine Scheme(Jiegu Xusun Decoction Combined with Du Jiu)on Elderly Patients with Delayed Union of Femoral Fractures

中文摘要英文摘要

目的:探讨接骨续损汤联合督灸对老年股骨骨折延迟愈合(伤后3~6个月X线片示骨折线清晰、无明显骨痂生长)患者受损组织微循环、破骨细胞重建及血清Leptin、Runx2的影响.方法:选择2023年8月至2024年10月收治的老年股骨骨折延迟愈合患者96例,采用随机数字表法分为对照组和研究组(各48例).两组均采取常规西医干预,对照组在此基础上给予督灸治疗,研究组在对照组治疗基础上采用接骨续损汤治疗,疗程均为12周.治疗前后分别采用激光多普勒血流仪检测激光多普勒血流灌注单位(LDFU),显微镜观察甲襞毛细血管评估甲襞微循环积分,电化学发光法检测血清Ⅰ型胶原羧基端肽(CTX-Ⅰ),酶联免疫吸附试验(ELISA)测定血清抗酒石酸酸性磷酸酶(TRAP)、瘦素(Leptin)和核心结合因子2(Runx2),Lane-Sandhu法进行X线骨痂评分,采用Harris髋关节评分和牛津髋关节评分(OHS评分)评估患者髋关节恢复情况.并记录不良反应,评估临床疗效.随访1年,比较两组并发症复发率.结果:研究组临床治疗优于对照组(P<0.05).研究组LDFU从(46.73±10.56)PU 升至(74.68±11.86)PU,对照组从(45.26±8.52)PU 升至(60.41±10.25)PU,组间差异有统计学意义(P<0.05).研究组甲襞微循环总积分从(8.11±1.32)分降低至(3.82±0.80)分,对照组甲襞微循环总积分从(8.10±1.25)分降低至(6.31±1.12)分,组间差异有统计学意义(P<0.05).研究组血清 CTX-Ⅰ 从(1.90±0.33)ng/mL 降低至(0.96±0.24)ng/mL,TRAP 从(15.43±2.44)U/L降低至(9.73±1.86)U/L;对照组血清 CTX-Ⅰ 从(1.86±0.35)ng/mL 降低至(1.34±0.22)ng/mL,TRAP从(15.20±2.38)U/L降低至(12.35±2.21)U/L,组间差异有统计学意义(P<0.05).研究组血清 Leptin 从(8.62±1.30)ng/mL 降低至(5.41±1.18)ng/mL,Runx2 从(23.05±5.24)ng/mL 升高至(36.62±5.22)ng/mL;对照组血清 Leptin 从(8.46±1.13)ng/mL 降低至(6.83±1.24)ng/mL,Runx2 从(22.75±4.56)ng/mL 升高至(30.54±5.15)ng/mL,组间差异有统计学意义(P<0.05).研究组 RUSH 评分从(13.10±2.35)分升至(23.81±4.10)分,Lane-Sandhu 评分从(1.78±0.40)分升高至(4.52±0.45)分,Harris 评分从(63.14±7.25)分升高至(80.36±5.74)分,OHS 评分从(22.03±4.20)分升高至(36.52±5.32)分;对照组 RUSH 评分从(12.56±2.14)分升至(19.73±3.82)分,Lane-Sandhu 评分从(1.75±0.35)分升高至(2.98±0.42)分,Harris 评分从(62.53±6.83)分升高至(75.63±5.68)分,OHS评分从(21.56±3.46)分升高至(29.73±4.26)分,组间差异有统计学意义(P<0.05).研究组骨密度从(0.64±0.06)g/cm2 升高至(0.75±0.09)g/cm2,骨小梁厚度(Tb.Th)从(0.11±0.03)mm 升高至(0.17±0.04)mm,骨痂体积(BV)从(0.87±0.12)cm3 升高至(1.57±0.25)cm3,骨小梁分离度(Tb.Sp)从(0.38±0.06)mm降低至(0.27±0.05)mm;对照组骨密度从(0.65±0.04)g/cm2 升高至(0.71±0.08)g/cm2,Tb.Th 从(0.12±0.03)mm 升高至(0.14±0.03)mm,BV 从(0.85±0.10)cm3 升高至(1.34±0.22)cm3,Tb.Sp 从(0.37±0.07)mm 降低至(0.30±0.05)mm,组间差异有统计学意义(P<0.05).研究组完全负重时间为术后(8.72±2.48)周,骨折线消失时间为术后(13.20±3.54)周;对照组完全负重时间为术后(10.47±2.15)周,骨折线消失时间为术后(15.16±3.38)周,组间差异有统计学意义(P<0.05).研究组并发症复发率4.17%低于对照组16.67%,差异有统计学意义(P<0.05).研究组骨密度改善幅度(0.52±0.18)g/cm2大于对照组(0.41±0.12)g/cm2,差异有统计学意义(t=3.523,P<0.05);研究组SF-36评分(82.36±6.45)分高于对照组(77.56±7.12)分,差异有统计学意义(t=3.462,P<0.05).对照组不良反应发生率为8.33%,研究组不良反应发生率为12.50%,两组比较差异无统计学意义(x2=0.447,P>0.05).结论:接骨续损汤联合督灸对老年股骨骨折延迟愈合患者具有一定的临床治疗作用,其机制与抑制破骨细胞活性、促进血管新生及调控Leptin/Runx2通路密切相关.

Objective:To investigate the effects of Jiegu Xusun decoction combined with Du Jiu(Du moxibustion)on mi-crocirculation,osteoclast remodeling,serum leptin,and Runx2 in elderly patients with delayed union of femoral fractures.Methods:A total of 96 elderly patients with delayed union of femoral fractures,who were admitted from August 2023 to October 2024,were selected and randomly divided into a control group and a study group using a random number table method.Both groups received conventional Western medical intervention.The control group was treated with Du Jiu on this basis,while the study group received Jiegu Xusun decoction on the basis of the treatment of the control group.The treatment course lasted 12 weeks.Before and after the treatment,the laser Doppler perfusion unit(LDFU)was detected by laser Doppler flowmeter,the nailfold capillaries were observed under a microscope to evaluate the nailfold microcircula-tion score,and the serum type Ⅰ collagen carboxyl-terminal peptide(CTX-Ⅰ)was detected by electrochemilumines-cence.Serum tartrate-resistant acid phosphatase(TRAP),leptin and core binding factor 2(Runx2)were determined by enzyme-linked immunosorbent assay(ELISA).X-ray callus score was performed by the Lane-Sandhu method.Harris hip score and Oxford hip score(OHS)were used to evaluate the hip joint recovery of patients.Record adverse reactions and evaluate clinical efficacy.The two groups were followed up for one year to compare the study rates of complications.Results:The clinical treatment of the research group was superior to that of the control group(P<0.05).The LDFU of the study group increased from(46.73±10.56)PU to(74.68±11.86)PU,while the control group increased from(45.26±8.52)PU to(60.41±10.25)PU.The difference between the groups was statistically significant(P<0.05).The total nailfold microcirculation score in the study group decreased from(8.11±1.32)points to(3.82±0.80)points,whereas that in the control group decreased from(8.10±1.25)points to(6.31±1.12)points.The difference between the groups was statistically significant(P<0.05).The serum CTX-Ⅰ of the study group decreased from(1.90±0.33)ng/mL to(0.96±0.24)ng/mL,and TRAP decreased from(15.43±2.44)U/L to(9.73±1.86)U/L;The serum CTX-Ⅰ of the control group decreased from(1.86±0.35)ng/mL to(1.34±0.22)ng/mL,and the TRAP decreased from(15.20±2.38)U/L to(12.35±2.21)U/L;There was a statistically significant difference between the groups(P<0.05).The serum leptin of the study group decreased from(8.62±1.30)ng/mL to(5.41±1.18)ng/mL,and Runx2 increased from(23.05±5.24)ng/mL to(36.62±5.22)ng/mL;The serum leptin of the control group decreased from(8.46±1.13)ng/mL to(6.83±1.24)ng/mL,and Runx2 increased from(22.75±4.56)ng/mL to(30.54±5.15)ng/mL;There was a statistically significant difference between the groups(P<0.05).The X-ray callus score of the study group increased from(1.78±0.40)points to(4.52±0.45)points,the Harris score increased from(63.14±7.25)points to(80.36±5.74)points,and the OHS score increased from(22.03±4.20)points to(36.52±5.32)points.The X-ray callus score of the control group increased from(1.75±0.35)points to(2.98±0.42)points,the Harris score in-creased from(62.53±6.83)points to(75.63±5.68)points,and the OHS score increased from(21.56±3.46)points to(29.73±4.26)points.There was a statistically significant difference between the groups(P<0.05).In the study group,BMD increased from(0.64±0.06)g/cm2 to(0.75±0.09)g/cm2,Tb.Th increased from(0.11±0.03)mm to(0.17±0.04)mm,BV increased from(0.87±0.12)cm3 to(1.57±0.25)cm3,and Tb.Th decreased from(0.38±0.06)mm to(0.27±0.05)mm.In the control group,BMD increased from(0.65±0.04)g/cm2 to(0.71±0.08)g/cm2,Tb.Th increased from(0.12±0.03)mm to(0.14±0.03)mm,BV increased from(0.85±0.10)cm3 to(1.34±0.22)cm3,and Tb.Th decreased from(0.37±0.07)mm to(0.30±0.05)mm.The intergroup differences were statistically significant(P<0.05).The recurrence rate of complications in the study group was 4.17%,which was lower than that in the control group(16.67%),and the difference was statistically significant(P<0.05).The improvement in BMD in the study group(0.52±0.18)was greater than that in the control group(0.41±0.12)(t=3.523,P<0.05),and the SF-36 score(82.36±6.45)was higher than that in the control group(77.56±7.12)(t=3.462,P<0.05).The incidence of adverse reactions was 8.33%in the control group and 12.50%in the study group.There was no statistically significant difference between the two groups(x2=0.447,P>0.05).Conclusion:The combination of Jiegu Xusun decoction and Du Jiu has a posi-tive clinical therapeutic effect on elderly patients with delayed union of femoral fractures.Its mechanism is closely associated with inhibition of osteoclast activity,promotion of angiogenesis,and regulation of the leptin/Runx2 signaling pathway.

李安;潘俊曦;冯庆辉;张胜

广州医科大学附属中医医院(广州,510000)广州医科大学附属中医医院(广州,510000)广州医科大学附属中医医院(广州,510000)广州医科大学附属中医医院(广州,510000)

医药卫生

接骨续损汤督灸股骨骨折延迟愈合微循环破骨细胞瘦素

Jiegu Xusun decoctionDu Jiufemoral fracturedelayed unionmicrocirculationosteoclastsleptin

《中国中医骨伤科杂志》 2026 (9)

49-57,9

广东省中医药局科研项目(20212173)

10.20085/j.cnki.issn1005-0205.260908

评论